run for her

ovarian cancer research and awareness

Run For Her History
Event Information
2011 Sponsors
Event FAQ's
Sponsor the Event
Ovarian Cancer Awareness
Personal Stories
2006 Sponsors
Corporate Matching Gifts
Incentive Levels
Incentive & Raffle Prizes
run for her History
2007 Sponsors
Race Results
Downloadable Forms
Contact Us
2008 Winners!
2009 Sponsors
run for her - 2 col
run for her - 3 col
run for her - subpage
run for her - buttons
run for her - tabs
rfh2011 - About
rfh2011- Details
rfh2011- History
rfh2011- Nanci Sargent Happy Matters
rfh2011- Packet Pick Up
rfh2011- Register
rfh2011- Stories
rfh2011- Training Series
rfh2011 - Event
rfh2011 - Donate
rfh2011 - Make a Donation
rfh2011 - Donate to a Participant
rfh2011 - Corporate Matching Gifts
rfh2011 - GoodShop
rfh2011 - Teams
rfh2011 - Basics
rfh2011 - Letter
rfh2011 - Handbook
rfh2011 - Team FAQ
rfh2011 - Toolkit
rfh2011 - Personalize Bib
rfh2011 - Personal Page Tips
rfh2011 - Fundraising Tips
rfh2011 - Share Tools
rfh2011 - Awareness
rfh2011 - Ovarian Cancer Awareness
rfh2011 - Resources
rfh2011 - Clincal Trials
rfh2011 - FAQ
rfh2011 - contact us
rfh2011 - sponsors
rfh2011 - sleepwalkers
rfh2011 - Links
rfh2011 - Ovarian FAQ
rfh2011 - Social Media Policy
rfh2011 - Privacy Policy
rfh2011 - Terms and Conditions
rfh2011 - Downloadable Forms
rfh2011 - Facebook Badge FAQ
rfh2011 - Facebook Tag Contest
rfh2011 - Media Page
rfh2011 - Finish Line Festival
rfh2011 - shop for her
rfh2011 - livestream test page
rfh2011 - Prizes
Editorial Policies and Guidelines
Join Us
Sponsor a Participant
Spread the Word
Donate to the Cause
Finish Line Festival
My Personal Page
Main Login
Email Friends
Enter my HQ
Edit my Site
Check Reports
Use Tools

Resources at Cedars-Sinai Medical Center

  • Clinical Trials

    The Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute offers a wide range of clinical trials investigating the effectiveness of targeted therapies for women fighting ovarian cancer. If you are interested in learning more about our current clinical trials, you may access the Cedars-Sinai Protocol Library to search, or contact Glaucia Vasquez.

  • Division of Gynecologic Oncology

    Each year, 82,000 women in the United States learn they have a gynecologic cancer. Although these cancers are often grouped together, they vary widely in their causes, risk factors, detection, treatment and chance of a cure.

  • Gilda Radner Cancer Program

    Beth Y. Karlan, MD founded the Gilda Radner Hereditary Cancer Program in 1991 to focus on individuals with a family history of breast and ovarian cancers. The program contributed to research efforts that helped to identify BRCA 1 and BRCA 2 mutations. Since that time, we have expanded the program to include multiple studies that are all aimed at improving our understanding of what other factors may impact the age of onset of cancers, the effectiveness of treatments, and quality of life. Currently, we are recruiting research participants for the following programs:

    1. The Gilda Radner Program: The purpose of this program is to investigate the many factors associated with being at higher risk for cancer due to BRCA 1 and BRCA 2 alterations. All persons (women and men) with a documented BRCA mutation can enroll. Participation includes completing a questionnaire annually and providing a blood specimen if possible.
    2. The Novel Markers Trial: This trial is designed to assess the effectiveness of a new tumor marker, HE4, in combination with CA125 and ultrasound to detect early ovarian cancer in high risk patients. If you have a family history of ovarian cancer and/or breast cancer and at least one ovary, you may be eligible to participate. Participation includes blood draws every six months in conjunction with regular standard of care screening.

    If you would like more information or would like to discuss our programs, please contact Hayley Russ or visit our website.

Resources on the Web

Help Files